CATLIN AVERY W

CIK 00012553483 companiesHINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001255348

Recent Transactions

50 trades

Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock, par value $0.0001 per share
2024-05-30+2,783→ 4,350 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2024-05-16+2,783→ 2,783 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2023-05-18+5,300→ 5,300 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−22,200→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−24,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−23,000→ 0 total
Disposition from Tender
Provention Bio, Inc.
Common Stock
2023-04-27−10,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−33,000→ 0 total
Disposition from Tender
Provention Bio, Inc.
Common Stock
2023-04-27−10,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−128,981→ 0 total
Gift
Provention Bio, Inc.
Common Stock
2023-04-13+10,000→ 10,000 total
Gift
Provention Bio, Inc.
Common Stock
2023-04-13−10,000→ 10,000 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2022-05-18+79,600→ 79,600 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2022-05-17+33,000→ 33,000 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2021-06-17+58,200→ 58,200 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2021-06-17+58,200→ 58,200 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2021-05-12+23,000→ 23,000 total
Award
Provention Bio, Inc.
Option (right to buy)
2020-07-15+22,200→ 22,200 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2020-05-20+40,500→ 40,500 total
Award
Provention Bio, Inc.
Option (right to buy)
2019-06-24+24,000→ 24,000 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2019-05-22+33,300→ 33,300 total
Purchase
Provention Bio, Inc.
Common Stock
2018-12-26$1.85/sh+5,000→ 20,000 total
Purchase
Provention Bio, Inc.
Common Stock
2018-12-24$1.90/sh+5,000→ 15,000 total
Purchase
Provention Bio, Inc.
Common Stock
2018-11-09$3.15/sh+10,000→ 10,000 total
Award
Provention Bio, Inc.
Option (right to buy)
2018-09-05+128,981→ 128,981 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2018-05-24+34,000→ 34,000 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2017-05-25+30,500→ 30,500 total
Purchase
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock
2017-05-11$6.15/sh+5,000→ 47,000 total
Purchase
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock
2016-11-22$7.55/sh+2,000→ 42,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Employee Stock Option (right to buy)
2016-09-02−10,000→ 25,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock, par value $0.001 per share
2016-09-02$2.80/sh+10,000→ 83,586 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2016-06-08+135,000→ 135,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2016-06-03−2,847→ 5,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2016-06-03−20,000→ 0 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock, par value $0.001 per share
2016-06-03$2.80/sh+20,000→ 70,739 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock, par value $0.001 per share
2016-06-03$4.50/sh+2,847→ 73,586 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2016-05-26+50,000→ 50,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock, par value $0.001 per share
2016-03-09$2.80/sh+15,000→ 50,739 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2016-03-09−15,000→ 20,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2015-11-23$8.52/sh+25,000→ 60,109 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2015-11-23$18.00/sh−25,000→ 35,109 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option
2015-11-23−25,000→ 0 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2015-09-11−10,000→ 7,847 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock, par value $0.001 per share
2015-09-11$4.50/sh+10,000→ 35,109 total
Purchase
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock
2015-08-18$1.90/sh+8,212→ 40,000 total
Purchase
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock
2015-08-17$1.90/sh+1,788→ 31,788 total
Purchase
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock
2015-08-17$1.95/sh+5,000→ 30,000 total
Purchase
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock
2015-08-17$1.94/sh+5,000→ 25,000 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2015-08-12+20,000→ 20,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2015-06-15$8.52/sh+25,000→ 49,609 total

Companies

Recent Filings

Address

241 CENTRAL STREET

HINGHAM, MA, 02043

View on SEC.gov